cariprazine


( Last Updated : October 1, 2021)
Generic Name:
cariprazine
Project Status:
Pending
Therapeutic Area:
Schizophrenia
Manufacturer:
AbbVie Canada
Call for patient/clinician input open:
Brand Name:
TBC
Project Line:
Reimbursement Review
Project Number:
SR0708-000
Call for patient/clinician input closed:

Details


Manufacturer Requested Reimbursement Criteria1:
For the acute and long-term maintenance of schizophrenia in adults.
Fee Schedule:
Pending
Indications:
Cariprazine is anticipated to be indicated for the acute and long-term maintenance treatment of schizophrenia in adults.
Anticipated Date:
  1. The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.